Janice Brown, MD

Janice Brown, MD

BMT specialist, Infectious disease doctor, Blood and marrow transplant specialist

Bio:   Dr. Janice (Wes) Brown specializes in the treatment of infectious complications that occur in patients who are receiving cancer treatments or are undergoing transplantation of solid organs or hematopoietic cells. She has been a member of the Blood and Marrow Transplantation faculty for more than twenty years and co-founded the Immunocompromised Host Infectious Diseases consultation service. Dr. Brown’s special interest is to understand the nature of immunodeficiency resulting from an ever- evolving spectrum of targeted and immunomodulatory therapy. Her laboratory studies approaches to enhance and/or rebuild protective immunity. She is a leader in the design and execution of clinical trials of new treatments for infections that have significantly improved the outcomes of high-risk patients.

Blood and Marrow Transplant Program (BMT)

  • 875 Blake Wilbur Drive
  • Clinic E, 1st Floor
  • Palo Alto, CA 94304
  • Phone: 650-723-0822
More Clinic Information » Insurance Coverage » Getting Here » Make An Appointment

Hematology Program

  • 875 Blake Wilbur Drive
  • Clinic C
  • Palo Alto, CA 94304
  • Phone: 650-498-6000
More Clinic Information » Insurance Coverage » Getting Here » Make An Appointment

Professional Education

  • Medical Education: University Of Virginia (1987) VA
  • Fellowship: Stanford University School of Medicine (1993) CA
  • Residency: Stanford University School of Medicine (1990) CA
  • Internship: Stanford University School of Medicine (1988) CA
  • BA, Stanford University, Biological Sciences (1981)
  • MD, University of Virginia, Hypoxemic myocardial injury (1987)
  • Residency, Stanford University, Internal Medicine (1990)
  • Fellowship, Stanford University, Infectious Diseases (1996)

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.